NCT02679131 2019-11-20To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.Acrotech Biopharma Inc.Phase 1 Terminated18 enrolled
NCT01907802 2018-08-14Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver DysfunctionNational Cancer Institute (NCI)Phase 1 Terminated8 enrolled